Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Clinical trial NCT03509896 · COMPLETED
Trial details
- NCT number
- NCT03509896
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-30
- Primary completion
- 2019-06-07
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.